Prospective Validation of Gallium-68 PSMA-PET/CT in Primary Staging of Prostate Cancer Patients.

Prospective validation of gallium-68 (68Ga) prostate specific membrane antigen (PSMA)-PET/CT in initial staging of prostate cancer is lacking. This study evaluates diagnostic accuracy of 68Ga-PSMA-PET/CT in detection of lymph node metastases in patients with intermediate-high risk prostate cancer. From October 2017 to October 2018, newly diagnosed prostate cancer patients with negative bone scan and >10% […]

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.

Previous communication has reported significant improvement in overall survival (OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular cancer (HCC). To determine if doxorubicin added to sorafenib therapy improves OS, with stratification for locally advanced and metastatic disease. This unblinded randomized phase 3 clinical trial was led by Alliance in collaboration with […]

Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma.

Renal carcinoma is the second most common cancer in the urinary system with an increasing trend. The major treatment for renal carcinoma is surgery, which results in unfavorable prognosis at times. As a tissue-specific marker for tumor, microRNA (miR) exerts its functions via facilitating oncogenic gene expression or suppressing tumor suppressor gene. MiR-184 is known […]

[Use of Modafinil in Co-existing Major Depression and ErectileDysfunction: A Case Report].

Erectile dysfunction is a sexual dysfunction which is commonlycomorbid with major depression. Antidepressant treatment does notalways improve comorbid sexual dysfunctions in major depression. Infact, sexual dysfunction may worsen or get complicated following theintroduction of antidepressants. Modafinil is a drug with stimulanteffect on the central nervous system by binding to norepinephrineand dopamine transporters and consequently increasing […]

Pediatric Kidney Transplant Outcomes in Children with Primary Urologic Abnormalities Compared to Children with Non-urologic Abnormalities: Long-Term Results.

To assess renal function, graft survival rates and the risk of graft loss in children based on the etiology with focus on differences between urologic causes from congenital anomalies of the kidney and urinary tract (CAKUT) versus other causes of end-stage kidney disease (ESKD). A retrospective chart review was performed that included patients <18 years […]

Largest Real-World Study of Immunotherapy Shows Men with Advanced Prostate Cancer with Low PSA had a Median Survival of Nearly Four Years after Treatment with PROVENGE® (sipuleucel-T)

San Francisco, CA (UroToday.com) — Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy, announced the publication of results from its PROCEED registry, which evaluated real-world use of PROVENGE®(sipuleucel-T) in men with asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer (mCRPC). The findings, published in Cancer1 showed that men with mCRPC who were […]

Real‐world Outcomes of Sipuleucel‐T Treatment in PROCEED, A Prospective Registry of Men with Metastatic Castration‐resistant Prostate Cancer

Background: The large registry, PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data (PROCEED) (NCT01306890), evaluated sipuleucel‐T immunotherapy for asymptomatic/minimally symptomatic metastatic castration‐resistant prostate cancer (mCRPC). Methods: PROCEED enrolled patients with mCRPC receiving 3 biweekly sipuleucel‐T infusions. Assessments included overall survival (OS), serious adverse events (SAEs), cerebrovascular events (CVEs), and anticancer interventions (ACIs). Follow‐up was […]

Minimum Number of MRI Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective Lesion-Based Analyses of Patients Treated with Radical Prostatectomy.

To analyze the number of mpMRI targeted biopsy (TBx) cores per lesion needed for PCa detection in patients treated with radical prostatectomy (RP). Analyses focus on TBx of PCa suspicious MRI lesions (PI-RADS ≥3) with consecutive RP. Descriptive statistics included frequencies/proportions and interquartile ranges (IQR). Multivariable logistic regression analyses (MVA) on per lesion level predicted […]

X